16-1535
Showing 1 - 25 of 5,042
Asthma Trial (Beclomethasone Dipropionate/Formoterol Fumarate, Beclomethasone Dipropionate)
Not yet recruiting
- Asthma
- Beclomethasone Dipropionate/Formoterol Fumarate
- Beclomethasone Dipropionate
- (no location specified)
Mar 14, 2022
Asthma Trial in Pisa (CHF1535 200/6 µg, BDP 100 µg)
Completed
- Asthma
- CHF1535 200/6 µg
- BDP 100 µg
-
Pisa, ItalyCardio-Thoracic and Vascular Dept, University of Pisa
Oct 28, 2021
High Grade Glioma Trial in Phoenix (BDTX-1535)
Not yet recruiting
- High Grade Glioma
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Oct 2, 2023
Neuroendocrine Tumors Trial in Boston, New York, Houston (LEE011, everolimus)
Active, not recruiting
- Neuroendocrine Tumors
-
Boston, Massachusetts
- +4 more
Feb 22, 2022
Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases
Not yet recruiting
- Multi-Drug Resistant Hiv-1 Infection
- HIV-1 Infection
- UB-421
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Patient Decision Aid, Treatment As Usual Trial in Heidelberg, Dresden (Patient Decision Aid)
Completed
- Patient Decision Aid
- Treatment As Usual
- Patient Decision Aid
-
Heidelberg, Baden-Württemberg, Germany
- +1 more
Nov 2, 2022
Mesenchymal Chondrosarcoma Trial in Italy (Trabectedin)
Active, not recruiting
- Mesenchymal Chondrosarcoma
-
Prato, Firenze, Italy
- +5 more
Oct 29, 2021
Traumatic Brain Injury, Intracranial Hypertension Trial in London (nICP)
Completed
- Traumatic Brain Injury
- Intracranial Hypertension
- nICP
-
London, England, United KingdomRoyal London Hospital
Nov 18, 2022
Blocking TNF to Potentiate ICI-dependent Immune Awakening in
Recruiting
- Melanoma
- +2 more
-
Toulouse, FranceInstitut Claudius Regaud
May 25, 2023
Asthma in Children Trial in Copenhagen, (free comb. beclomethasone DPI and formoterol DPI, CHF 1535 50/6 NEXT DPI)
Completed
- Asthma in Children
- free comb. beclomethasone DPI and formoterol DPI
- CHF 1535 50/6 NEXT DPI
-
Copenhagen,, DenmarkBørneAstmaKlinikken, Hans Knudsens Plads 1A,
Jul 30, 2020
Brain Metastases, Brain Cancer Trial in Miami (18F-Fluciclovine)
Not yet recruiting
- Brain Metastases
- Brain Cancer
-
Miami, FloridaMiami Cancer Institute at Baptist Health South Florida
Jan 3, 2023
COPD Trial in Paris (Beclomethasone 100 µg plus formoterol 6 µg (CHF1535) pMDI, Budesonide 200 µg plus formoterol 6 µg DPI,
Completed
- Chronic Obstructive Pulmonary Disease
- Beclomethasone 100 µg plus formoterol 6 µg (CHF1535) pMDI
- +2 more
-
Paris, FranceThomas Similowski
Oct 28, 2021
Asthma Trial in Copenhagen (CHF1535 pMDI + AC Plus, BDP + AC Plus, Formoterol + AC Plus)
Completed
- Asthma
- CHF1535 pMDI + AC Plus
- +2 more
-
Copenhagen, DenmarkBorneAstmaKlinikken
Jul 30, 2020
Pancreatic Cancer Stage IV Trial in United States (CBP501 (16), CBP501 (25), Cisplatin)
Active, not recruiting
- Pancreatic Cancer Stage IV
- CBP501 (16)
- +3 more
-
Tucson, Arizona
- +19 more
Aug 16, 2022
Asthma Trial in Copenhagen, Manchester (CHF1535 NEXT DPI, BDP DPI and formoterol DPI)
Completed
- Asthma
- CHF1535 NEXT DPI
- BDP DPI and formoterol DPI
-
Copenhagen, Denmark
- +1 more
Jul 30, 2020
COPD Trial in Manchester (CHF 1535 NEXThaler 800/48, CHF 1535 NEXThaler 200/12, CHF 1535 NEXThaler PLACEBO)
Completed
- COPD
- CHF 1535 NEXThaler 800/48
- +4 more
-
Manchester, United KingdomMedicine Evaluation Unit
Oct 28, 2021
Generalized Convulsive Status Epilepticus Trial in Sohag (Ketamine, Midazolam, Placebo)
Recruiting
- Generalized Convulsive Status Epilepticus
- Ketamine
- +2 more
-
Sohag, EgyptSohag University Hospital
Mar 21, 2023
Status Epilepticus, Generalized Convulsive Status Epilepticus, Status Epilepticus, Generalized Trial in Sohag (Levetiracetam,
Completed
- Status Epilepticus
- +3 more
- Levetiracetam
- +2 more
-
Sohag, EgyptDepartment of Pediatrics - Sohag University Hospital
Sep 17, 2022
Cervical Cancer, Recurrent Cervical Cancer, Metastatic Cervical Cancer Trial in Mobile (Cabozantinib 40 MG oral once a day,
Terminated
- Cervical Cancer
- +3 more
- Cabozantinib 40 MG oral once a day
- Pembrolizumab 200 mg IV every 3 weeks
-
Mobile, AlabamaUniversity of South Alabama Mitchell Cancer Institute
Jun 3, 2022
Patient Undergoing Surgery Trial in Istanbul (aromatherapy, Placebo)
Completed
- Patient Undergoing Surgery
- aromatherapy
- Placebo
-
Istanbul, TurkeyÇağla
Jan 19, 2023
P0.1 and Extubation Failure in Critically Ill Patients
Not yet recruiting
- Weaning Failure
- +2 more
- Reintubation
-
Amiens, France
- +2 more
Mar 25, 2023
Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)
Recruiting
- Core Binding Factor Acute Myeloid Leukemia
- KIT Mutation-Related Tumors
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital of Soochow University
Apr 7, 2023
Cardiovascular Disease, Diabetes, Type 2 Trial in Milwaukee (Goodbelly first, Placebo first)
Recruiting
- Cardiovascular Disease
- Diabetes Mellitus, Type 2
- Goodbelly first
- Placebo first
-
Milwaukee, WisconsinMedical College of Wisconsin
Dec 13, 2022
Infant Development Trial (Infant Formula)
Not yet recruiting
- Infant Development
- Infant Formula
- (no location specified)
Jul 17, 2023